首页 | 本学科首页   官方微博 | 高级检索  
     

RP-HPLC法测定施普睿达原料药中主药的含量
引用本文:徐阳,刘培勋,禹洁,王育苗,龙伟,马世堂. RP-HPLC法测定施普睿达原料药中主药的含量[J]. 中国药房, 2010, 0(13): 1231-1232
作者姓名:徐阳  刘培勋  禹洁  王育苗  龙伟  马世堂
作者单位:中国医学科学院北京协和医学院,放射医学研究所,天津分子核医学重点实验室,天津市300192
基金项目:天津市科技计划项目(072CKFSH00200)
摘    要:目的:建立反相高效液相色谱法(RP-HPLC)测定施普睿达原料药中主药含量的方法。方法:色谱柱为SunFireTMRPC18,流动相为磷酸盐缓冲溶液-乙腈(9∶1,V/V),流速为1mL·min-1,检测波长为220nm,进样量为10μL,柱温为25℃。结果:施普睿达检测浓度线性范围为0.004~0.5mg·mL-1(R2=0.9999),平均加样回收率为100.0%(n=9),RSD=0.23%(n=6)。结论:该方法系统适用性好、简便、准确可靠、重复性好,适合施普睿达的含量测定。

关 键 词:反相高效液相色谱法  施普睿达  含量测定

Content Determination of Main Component of Sprida Crude Drug by RP-HPLC
XU Yang,LIU Pei-xun,YU Jie,WANG Yu-miao,LONG Wei,MA Shi-tang. Content Determination of Main Component of Sprida Crude Drug by RP-HPLC[J]. China Pharmacy, 2010, 0(13): 1231-1232
Authors:XU Yang  LIU Pei-xun  YU Jie  WANG Yu-miao  LONG Wei  MA Shi-tang
Affiliation:(Chinese Academy of Medical Sciences Peking Union Medical College, Institute of Radiation Medicine, Tianjin Key Laboratory of Molecular Biology and Nuclear Medicine, Tianjin 300192, China)
Abstract:OBJECTIVE: To establish an RP-HPLC method for the determination of Sprida in its crude drug. METHODS: The separation was performed on SunFireTM RP C18 column with mobile phase consisted of phosphate buffer solution-acetonitrile (9: 1, V/V) and a flow rate of 1 mL·min^-1. The detection wavelength was set at 220 nm, injection volume 10 μL and column temperature 25 ℃. RESULTS: The linear range of Sprida was 0.004-0.5 mg·mL^-1(R^2=0.999 9) with an average recovery of 100.0% (n=9) and RSD was 0.23% (n=6). CONCLUSION: The method is feasible, simple, accurate, reliable and reproducible for the content determination of Sprida.
Keywords:RP-HPLC  Sprida  Content determination
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号